S&P 500   4,576.01 (+0.03%)
DOW   35,659.22 (-0.27%)
QQQ   382.12 (+0.79%)
AAPL   149.33 (+0.01%)
MSFT   323.76 (+4.40%)
FB   315.44 (-0.12%)
GOOGL   2,956.75 (+6.12%)
TSLA   1,051.03 (+3.20%)
AMZN   3,399.17 (+0.68%)
NVDA   248.76 (+0.64%)
BABA   168.97 (-0.60%)
NIO   39.81 (-1.63%)
CGC   13.02 (-1.14%)
GE   104.15 (-3.06%)
AMD   124.40 (+1.20%)
MU   68.33 (-0.88%)
T   25.19 (-0.71%)
F   15.73 (-1.32%)
ACB   6.96 (-1.00%)
DIS   169.69 (-1.37%)
PFE   42.85 (-1.63%)
BA   207.30 (-1.20%)
AMC   35.35 (-1.94%)
S&P 500   4,576.01 (+0.03%)
DOW   35,659.22 (-0.27%)
QQQ   382.12 (+0.79%)
AAPL   149.33 (+0.01%)
MSFT   323.76 (+4.40%)
FB   315.44 (-0.12%)
GOOGL   2,956.75 (+6.12%)
TSLA   1,051.03 (+3.20%)
AMZN   3,399.17 (+0.68%)
NVDA   248.76 (+0.64%)
BABA   168.97 (-0.60%)
NIO   39.81 (-1.63%)
CGC   13.02 (-1.14%)
GE   104.15 (-3.06%)
AMD   124.40 (+1.20%)
MU   68.33 (-0.88%)
T   25.19 (-0.71%)
F   15.73 (-1.32%)
ACB   6.96 (-1.00%)
DIS   169.69 (-1.37%)
PFE   42.85 (-1.63%)
BA   207.30 (-1.20%)
AMC   35.35 (-1.94%)
S&P 500   4,576.01 (+0.03%)
DOW   35,659.22 (-0.27%)
QQQ   382.12 (+0.79%)
AAPL   149.33 (+0.01%)
MSFT   323.76 (+4.40%)
FB   315.44 (-0.12%)
GOOGL   2,956.75 (+6.12%)
TSLA   1,051.03 (+3.20%)
AMZN   3,399.17 (+0.68%)
NVDA   248.76 (+0.64%)
BABA   168.97 (-0.60%)
NIO   39.81 (-1.63%)
CGC   13.02 (-1.14%)
GE   104.15 (-3.06%)
AMD   124.40 (+1.20%)
MU   68.33 (-0.88%)
T   25.19 (-0.71%)
F   15.73 (-1.32%)
ACB   6.96 (-1.00%)
DIS   169.69 (-1.37%)
PFE   42.85 (-1.63%)
BA   207.30 (-1.20%)
AMC   35.35 (-1.94%)
S&P 500   4,576.01 (+0.03%)
DOW   35,659.22 (-0.27%)
QQQ   382.12 (+0.79%)
AAPL   149.33 (+0.01%)
MSFT   323.76 (+4.40%)
FB   315.44 (-0.12%)
GOOGL   2,956.75 (+6.12%)
TSLA   1,051.03 (+3.20%)
AMZN   3,399.17 (+0.68%)
NVDA   248.76 (+0.64%)
BABA   168.97 (-0.60%)
NIO   39.81 (-1.63%)
CGC   13.02 (-1.14%)
GE   104.15 (-3.06%)
AMD   124.40 (+1.20%)
MU   68.33 (-0.88%)
T   25.19 (-0.71%)
F   15.73 (-1.32%)
ACB   6.96 (-1.00%)
DIS   169.69 (-1.37%)
PFE   42.85 (-1.63%)
BA   207.30 (-1.20%)
AMC   35.35 (-1.94%)

AB InBev Beats Revenue Views, But Shares Down On Inflation Challenges

Friday, July 30, 2021 | Kate Stalter
AB InBev Beats Revenue Views, But Shares Down On Inflation Challenges

The party is back on if you use Anheuser-Busch InBev (NYSE: BUD) second-quarter sales as your benchmark.

However, investors were in no mood for celebration, sending shares of the world’s biggest brewer lower following Thursday’s earnings report. 

The stock gapped down at the open, as AB InBev reported frothy revenue that topped pre-pandemic territory. However, with costs on the rise (a familiar refrain these days), profit failed to meet Wall Street views. 

In fact, AB InBev joins other food producers citing inflationary challenges tightening the grip on profitability. For example, Nestle (OTC: NSRGY) updated its guidance - and not in a good way. The Swiss food and beverage giant had earlier said it expected greater profitability this year, but now says higher costs will lower that bottom-line number. 

AB InBev earned $0.95 per share on revenue of $13.50 billion, year-over-year gains of 107% and 32% respectively. 

In its full-year outlook, the company said: 

  • EBITDA is expected to grow between 8-12%, while revenue growth stays ahead of that “from a healthy combination of volume and price. The outlook for FY21 reflects our current assessment of the scale and magnitude of the Covid-19 pandemic, which is subject to change as we continue to monitor ongoing developments.”
  • When it comes to cost of capital, AB InBev expects the average gross debt coupon in FY21 to be approximately 4.0%. 
  • The company sees pension interest expenses and accretion expenses being in the range of $140 to $160 million per quarter, dependent upon currency fluctuations. 
  • AB InBev expects an effective tax rate in the range of 28% to 30%. That’s an increase over 2020, which the company says is due to factors including the “phasing out of temporary Covid-19 measures and changes to tax attributes in some key markets. The ETR outlook does not consider the impact of potential future changes in legislation,” the company said. 
  • The company expects net capital expenditure between $4.5 and $5 billion as it boosts investment “in innovation and other consumer-centric initiatives to fuel our momentum.”

In its earnings release, the company discussed some of its projects aimed at product innovation. For example, it cited the success of its Brahma Duplo Malte in Brazil, which continues to lead the core pure malt segment, leveraging the company’s “prove and move” strategy.

That means fast-tracking new product development, aimed at shrinking time to launch from as much as two years, down to 100 days. To achieve that goal, the company uses local test markets to get fast customer feedback. Once the demand is proven, the company can move on the broader launch. 

Thursday’s earnings release also noted growth in its B2B platform, Bees, which allows small and medium-sized retailers to place orders, manage deliveries and invoices and track their ordering data. 

Meanwhile, the company has also been growing direct-to-consumer online ordering and courier delivery of beer in countries where the service is allowed. 

Although the stock is up 24.16% on a one-year basis, it’s struggled more recently. Year-to-date, AB InBev is down 1.19%. It’s down 3.15% in the past three months. 

The stock has clearly struggled to emerge from the great 2020 Covid meltdown, as sales at bars, restaurants, stadiums, concerts and other outside-the-home venues declined sharply. Even soft drink companies, such as Coca-Cola (NYSE: KO), suffered the same fate for the same reason. Coke’s stock has also lagged the broader market year-to-date.

AB InBev cleared a cup-with-handle base in early May, when it last reported earnings. Shares rallied to a high of $79.67 on June 15, before pulling into a new correction. The stock moved lower in six of the past seven weeks, and is now 3.4% below its 200-day moving average, meaning institutional investors were more eager to sell out than support existing positions.

Clearly, that means the stock is not a buy at this time, as it’s impossible to tell how much further it may fall. As of mid-session Thursday, shares were trading at $65.27, a decline of $3.36, or 4.9%. 

Should you invest $1,000 in Anheuser-Busch InBev SA/NV right now?

Before you consider Anheuser-Busch InBev SA/NV, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anheuser-Busch InBev SA/NV wasn't on the list.

While Anheuser-Busch InBev SA/NV currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here

 


Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Anheuser-Busch InBev SA/NV (BUD)2.5$57.28+0.7%0.77%19.89Hold$73.75
The Coca-Cola (KO)2.8$55.61+2.1%3.02%29.74Buy$61.47
Compare These Stocks  Add These Stocks to My Watchlist 

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.